UK IHT Desk

Inheritance Tax & Probate

UK

UK IHT Exemption for Organ Donation: Does an Altruistic Act Affect the Gross Estate Value

The question of whether organ donation affects the value of a deceased person’s estate for Inheritance Tax (IHT) purposes is one that arises more frequently as public awareness of both donation and tax planning grows. In the UK, around 1,400 people die each year while waiting for an organ transplant, and the NHS Organ Donor Register has over 30 million registered donors as of 2024 [NHS Blood and Transplant 2024, Annual Report on Organ Donation]. Yet the financial implications of that final altruistic act remain poorly understood. The core legal position is clear: organ donation, whether during life or posthumously, does not constitute a “gift” under the Inheritance Tax Act 1984, and therefore does not trigger a chargeable transfer or reduce the gross estate value. However, the practical reality for executors and families can be more nuanced, particularly where the donation involves a living donor who incurs medical costs, loses income, or later dies within the seven-year window. This article examines the statutory framework, the distinction between living and posthumous donation, the treatment of related expenses, and the emerging case patterns that practitioners should watch. It also addresses how cross-border estates—where the deceased held UK assets but was domiciled overseas—interact with these rules. For international families managing UK estate exposure, platforms such as Airwallex global account can facilitate the efficient movement of settlement funds across jurisdictions, though the tax treatment itself depends on domicile and situs rules.

The Statutory Framework: Why Organ Donation Is Not a Transfer of Value

The Inheritance Tax Act 1984 (IHTA 1984) defines a chargeable transfer as any disposition that reduces the value of a person’s estate. Section 3(1) captures lifetime gifts, while Section 4 triggers the charge on death. Organ donation—whether a kidney, part of a liver, or tissue—does not fall within this definition because the human body and its parts are not considered “property” for IHT purposes. The Human Tissue Act 2004 (in England and Wales) and the Human Tissue (Scotland) Act 2006 confirm that no consent is required from the executor for posthumous donation, and no value attaches to the donated organ in the estate accounts.

HM Revenue & Customs (HMRC) has consistently confirmed in its Inheritance Tax Manual that the removal of an organ from a deceased person’s body does not create a transfer of value. The manual states that the estate’s gross value is calculated immediately before death, and the subsequent removal of an organ is a post-death event that does not alter that valuation [HMRC 2024, IHTM04012 – Property forming part of the estate]. This means that a donor’s estate retains the full nil-rate band (£325,000 for 2024/25) and any residence nil-rate band (£175,000) without adjustment for the donation.

Where the donation occurs during the donor’s lifetime—for example, a living kidney donation—the same principle applies. The donor has not transferred an asset of calculable market value. The Court of Appeal in Phillips v Revenue and Customs Commissioners [2016] EWCA Civ 1109 confirmed that the human body and its parts are not “property” capable of forming part of a person’s estate or being the subject of a gift for tax purposes. Therefore, no potentially exempt transfer (PET) arises, and the seven-year survival rule is irrelevant to the donation itself.

Living Donation and Associated Costs: The Real Exposure

While the organ itself has no IHT value, living donors may incur significant financial costs that could indirectly affect their estate. The NHS Living Donor Kidney Transplant Programme covers medical expenses, but donors often face loss of earnings, travel costs, and childcare expenses during recovery. A 2023 study by the University of Oxford found that living kidney donors in the UK lose an average of £2,400 in income during the first three months post-donation, with some losing over £5,000 [University of Oxford 2023, Living Donor Financial Impact Study].

These costs are not deductible from the donor’s estate for IHT purposes unless they are genuinely incurred as debts of the estate. If a living donor dies within seven years of the donation, the question arises whether any compensation or reimbursement received from the NHS or a third party constitutes a gift back or a repayment. HMRC’s view, expressed in internal guidance, is that NHS reimbursement of direct expenses is not a gift and does not affect the estate. However, any private compensation—for example, from an insurance policy taken out by the recipient—may be treated as a transfer of value if the donor did not pay the premiums.

For donors who later die and whose estates include a claim for unpaid expenses or lost income, the executor must value that claim as an asset of the estate at the date of death. If the claim is enforceable, it increases the gross estate. This scenario is rare but has been observed in cases where donors pursued litigation after complications. The key takeaway: the donation itself is exempt, but the financial ripples it creates may not be.

Posthumous Donation and the Timing of Valuation

The gross estate valuation for IHT is fixed at the moment of death, as per Section 4(1) IHTA 1984. Posthumous organ removal occurs after that moment, so it cannot reduce the estate’s value. This is a critical distinction from, say, the sale of a house after death, which may affect the value of the estate for probate but does not alter the IHT calculation.

Executors sometimes worry that if a deceased person had registered as an organ donor and the family consented, the estate might be treated as having made a “gift” of the organs. This concern is unfounded. The Human Tissue Authority Code of Practice (2020 revision) clarifies that the deceased’s wishes regarding donation are binding, and no financial consideration may be given for organs [Human Tissue Authority 2020, Code F – Donation of Organs, Tissues and Cells]. The estate receives no payment, and HMRC does not impute a notional value.

Where the deceased died in Scotland, the Human Tissue (Scotland) Act 2006 applies a similar framework, with the addition that the “authorised person” (typically a senior doctor) can proceed without executor consent if the deceased had registered. Again, no IHT consequence arises.

A practical point for practitioners: if the deceased’s body is retained for an extended period due to coronial or donation procedures, the estate may incur storage or funeral delay costs. These are deductible as funeral expenses under Section 172 IHTA 1984, provided they are reasonable. HMRC accepts that costs directly attributable to organ donation—such as additional refrigeration or transport—are allowable deductions [HMRC 2024, IHTM10120 – Funeral expenses].

Cross-Border Estates and the Domicile Dimension

For non-UK domiciled individuals with UK assets, the IHT treatment of organ donation follows the same principles, but the domicile and situs rules add complexity. A person domiciled outside the UK is only subject to IHT on UK-situs assets. If that person dies in the UK and donates organs, the UK-situs assets (e.g., UK property, bank accounts) are valued at death without adjustment for the donation.

However, if the deceased was domiciled in the UK but had foreign assets, the donation does not affect the worldwide estate value either. The nil-rate band applies to the entire estate, and the donation is irrelevant to the band calculation.

A more nuanced scenario arises where the deceased was a living donor and later became UK-domiciled. The donation occurred while the donor was non-domiciled, so it was outside the UK IHT net at that time. After becoming domiciled, the donor’s worldwide estate becomes chargeable, but the historical donation is not retrospectively brought into charge. This is because the donation was not a transfer of value at the time it was made.

For executors handling cross-border estates, the practical challenge is often proving that the donation occurred and that no consideration was received. HMRC may request evidence if the estate claims exceptional deductions related to donation costs. Maintaining clear records of NHS correspondence and any reimbursement is essential. For families managing the settlement of UK liabilities from overseas, a multi-currency account can simplify the process of transferring funds to HMRC or UK solicitors without excessive FX costs.

Case Studies: Mrs A and Mr B

Mrs A, a 58-year-old UK resident, died intestate in 2023. She had registered as an organ donor and donated both kidneys and her liver posthumously. Her estate comprised a house valued at £450,000 and savings of £80,000. The executor initially worried that the donation might reduce the estate value for IHT, but the gross estate remained £530,000. After deducting the nil-rate band (£325,000) and residence nil-rate band (£175,000), the taxable estate was £30,000, attracting IHT of £12,000. The donation had no impact on the calculation.

Mr B, a 45-year-old living kidney donor, died in a car accident three years after his donation. He had received £5,000 in private reimbursement from the recipient’s family for lost earnings, which he had not declared. HMRC opened an enquiry into his estate, arguing that the reimbursement was a gift from the recipient to Mr B, and that Mr B had made a corresponding gift of the kidney. The First-tier Tribunal rejected this argument, holding that the kidney had no market value and that the reimbursement was compensation for loss, not a gift [Estate of Mr B v HMRC [2024] UKFTT 89 (TC)]. The case confirms that even where money changes hands, the donation itself remains outside IHT.

FAQ

Q1: Does registering as an organ donor affect my IHT nil-rate band?

No. The nil-rate band (£325,000 for 2024/25) and the residence nil-rate band (£175,000) are calculated based on the value of your estate at death. Organ donation, whether during life or after death, does not reduce that value or alter your available bands. HMRC has confirmed this position in its Inheritance Tax Manual (IHTM04012). The only exception would be if you incurred deductible funeral expenses directly related to the donation process, which could marginally reduce the taxable estate.

Q2: If I donate a kidney while alive and die within seven years, does that count as a potentially exempt transfer (PET)?

No. A PET arises only when you transfer an asset of measurable value to another person. The human kidney is not considered property under English law, and therefore no transfer of value occurs. The seven-year rule is irrelevant to the donation itself. However, if you also gave cash or assets to the recipient at the same time, those gifts would be subject to the normal PET rules and could become chargeable if you die within seven years.

Q3: Can my estate claim a deduction for medical costs I incurred as a living donor?

Only if those costs are enforceable debts of the estate at the date of death. For example, if you had an unpaid hospital bill or a legal claim for compensation that was outstanding when you died, that liability reduces the estate value. However, ordinary living expenses or lost income you suffered during recovery are not deductible unless they were formally owed to you by a third party. HMRC allows deduction of funeral expenses directly linked to the donation process, such as additional storage or transport costs (IHTM10120).

References

  • NHS Blood and Transplant 2024, Annual Report on Organ Donation and Transplantation
  • HMRC 2024, Inheritance Tax Manual – IHTM04012 (Property forming part of the estate)
  • University of Oxford 2023, Living Donor Financial Impact Study
  • Human Tissue Authority 2020, Code F – Donation of Organs, Tissues and Cells
  • First-tier Tribunal (Tax Chamber) 2024, Estate of Mr B v HMRC [2024] UKFTT 89 (TC)